4.43
+0.6(+15.67%)
Currency In USD
| Previous Close | 3.83 |
| Open | 3.89 |
| Day High | 4.5 |
| Day Low | 3.88 |
| 52-Week High | 6.28 |
| 52-Week Low | 1.97 |
| Volume | 994,461 |
| Average Volume | 625,667 |
| Market Cap | 26.09M |
| PE | -4.26 |
| EPS | -1.04 |
| Moving Average 50 Days | 2.62 |
| Moving Average 200 Days | 3.25 |
| Change | 0.6 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $19.71 as of July 05, 2025 at a share price of $4.43. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 3 years ago, it would be worth $138.44 as of July 05, 2025 at a share price of $4.43.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance
GlobeNewswire Inc.
Jul 01, 2025 12:30 PM GMT
Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance TreatmentLITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS)
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
GlobeNewswire Inc.
Jun 26, 2025 12:30 PM GMT
Important Study Shows Vivos Technology to be a Safe and Highly Effective, Non-Surgical Alternative to Surgical Removal of Tonsils and Adenoids in ChildrenLITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
GlobeNewswire Inc.
Jun 11, 2025 12:30 PM GMT
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes Vivos’ business model pivot to target high patient volu